At a glance
ClinicalIndex Comparison RecordN/ACompleted· 149 enrolled
Drug / intervention
VenaTech Convertible Vena Cava Filter +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial
In Brief
A clinical study evaluating VenaTech Convertible Vena Cava Filter and Vena Cava Filter Conversion for Pulmonary Embolism. Completed, enrolled 149 participants across 11 sites.
Detailed Summary
The investigation is designed to verify that clinical use of the vena cava filter does not raise new questions of safety or effectiveness compared to currently-marketed permanent filters.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Embolism
CountriesUnited States
CollaboratorsBright Research Partners, NAMSA
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2010
Enrollment StartDec 2011
Primary CompletionSep 2015
TodayJul 2026
First PostedApr 29, 2010
Enrollment StartDec 1, 2011
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 16.2 years ago
Interventions
VenaTech Convertible Vena Cava Filterdevice
Prevention of Pulmonary Embolism
Vena Cava Filter Conversionprocedure
Conversion of VenaTech Convertible filter to open configuration.